(Q30434613)

English

A modified hTERT promoter-directed oncolytic adenovirus replication with concurrent inhibition of TGFbeta signaling for breast cancer therapy

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

14 September 2017

A modified hTERT promoter-directed oncolytic adenovirus replication with concurrent inhibition of TGFbeta signaling for breast cancer therapy (English)

1 reference

Europe PubMed Central

PMC publication ID

14 September 2017

oncolytic virus

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

9

1 reference

Europe PubMed Central

PMC publication ID

14 September 2017

author name string

Z Hu

1

1 reference

Europe PubMed Central

PMC publication ID

14 September 2017

J S Robbins

2

1 reference

Europe PubMed Central

PMC publication ID

14 September 2017

A Pister

3

1 reference

Europe PubMed Central

PMC publication ID

14 September 2017

M B Zafar

4

1 reference

Europe PubMed Central

PMC publication ID

14 September 2017

Z-W Zhang

5

1 reference

Europe PubMed Central

PMC publication ID

14 September 2017

J Gupta

6

1 reference

Europe PubMed Central

PMC publication ID

14 September 2017

K J Lee

7

1 reference

Europe PubMed Central

PMC publication ID

14 September 2017

K Newman

8

1 reference

Europe PubMed Central

PMC publication ID

14 September 2017

T Guise

10

1 reference

Europe PubMed Central

PMC publication ID

14 September 2017

P Seth

11

1 reference

Europe PubMed Central

PMC publication ID

14 September 2017

publication date

2 October 2009

1 reference

Europe PubMed Central

PMC publication ID

14 September 2017

Cancer Gene Therapy

1 reference

Europe PubMed Central

PMC publication ID

14 September 2017

17

1 reference

Europe PubMed Central

PMC publication ID

14 September 2017

4

1 reference

Europe PubMed Central

PMC publication ID

14 September 2017

235-243

1 reference

Europe PubMed Central

PMC publication ID

14 September 2017

Biology of breast cancer bone metastasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2841698

20 June 2018

Molecular biology of bone metastasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2841698

20 June 2018

Genetic determinants of cancer metastasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2841698

20 June 2018

Development of oncolytic adenovirus armed with a fusion of soluble transforming growth factor-beta receptor II and human immunoglobulin Fc for breast cancer therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2841698

20 June 2018

Future prospects for oncolytic therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2841698

20 June 2018

Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2841698

20 June 2018

Mechanisms and treatment for bone metastases.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2841698

20 June 2018

Breast cancer metastasis to bone: mechanisms of osteolysis and implications for therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2841698

20 June 2018

Vector-mediated cancer gene therapy: an overview

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2841698

20 June 2018

Ad-mTERT-delta19, a conditional replication-competent adenovirus driven by the human telomerase promoter, selectively replicates in and elicits cytopathic effect in a cancer cell-specific manner

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2841698

20 June 2018

The two faces of transforming growth factor beta in carcinogenesis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2841698

20 June 2018

Metastasis to bone: causes, consequences and therapeutic opportunities

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2841698

20 June 2018

Lifetime exposure to a soluble TGF-beta antagonist protects mice against metastasis without adverse side effects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2841698

20 June 2018

Cancer gene therapy: fringe or cutting edge?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2841698

20 June 2018

Malignant cells, directors of the malignant process: role of transforming growth factor-beta

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2841698

20 June 2018

TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2841698

20 June 2018

Cytotoxic effects of adenovirus-mediated wild-type p53 protein expression in normal and tumor mammary epithelial cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2841698

20 June 2018

A recombinant adenovirus expressing p27Kip1 induces cell cycle arrest and loss of cyclin-Cdk activity in human breast cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.72

21 January 2018

An oncolytic adenovirus expressing soluble transforming growth factor-beta type II receptor for targeting breast cancer: in vitro evaluation

1 reference

https://api.crossref.org/works/10.1038%2FCGT.2009.72

21 January 2018

Advantages and disadvantages of multiple different methods of adenoviral vector construction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2841698

26 November 2018

Adenovirus-mediated gene transfer to human breast tumor cells: an approach for cancer gene therapy and bone marrow purging

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2841698

26 November 2018

Identifiers

10.1038/CGT.2009.72

1 reference

Europe PubMed Central

PMC publication ID

14 September 2017

Dimensions Publication ID

0 references

release_jkbltvhocjfojgaw236zuwdxtm

1 reference

https://api.fatcat.wiki/v0/release/jkbltvhocjfojgaw236zuwdxtm

24 November 2022

based on heuristic

mapped directly with Wikidata item

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

14 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30434613&oldid=2175193196"